← Leaderboards
Scott J Rodig
Broad Institute, Inc.
$3,390,322
Attributed
$6,182,994
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,182,994 · 3
By mechanism
R01$3,742,682 · 1
R33$1,381,997 · 1
P01$1,058,315 · 1
Top collaborators
- Orr Ashenberg4 shared
- Fei Chen4 shared
- Ravindra Uppaluri1 shared
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Fei Chen$12,921,245
- Evan Z Macosko$39,501,347
- Angela Nicole Koehler$3,755,430
- Catherine Ju-Ying Wu$43,266,044
- Ramnik J Xavier$68,708,013
Others in their field
Other Emerging Leaders on “Sampling”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,167,581
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Scott Topper · Broad Institute, Inc.$77,958,806
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- Leonard Freedman · Leidos Biomedical Research, Inc.$60,323,945
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
Research focus
SamplingTumorTissuesTranscriptomicsCell CommunicationComputerized ToolsGenomicsMolecularResearch PersonnelSingle-Cell Rna SequencingQuality ControlResolutionCellsSpecimenPathologyTechnologyEquipmentGenesBiological MarkersNeoplastic CellBar CodesResistanceProtocols DocumentationProduction
Grant awards (7)
Dissecting CCL5 contribution to antigen specific T cell responses in head and neck cancers$3,742,682
R01 · FY2025 · DE
Pathology and Bioinformatics Core$520,743
P01 · FY2025 · CA · contact PI
Pathology and Bioinformatics Core$537,572
P01 · FY2024 · CA · contact PI
Clinical implementations of spatial transcriptomics in tumors$423,137
R33 · FY2022 · CA
IMAT-ITCR Collaboration: An integrated experimental and computational platform for analyzing the spatial organization of tumor clones$77,571
R33 · FY2022 · CA
Clinical implementations of spatial transcriptomics in tumors$431,771
R33 · FY2021 · CA
Clinical implementations of spatial transcriptomics in tumors$449,518
R33 · FY2020 · CA